Biotech startups in Melbourne, Australia
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| PolyActiva | Melbourne | Series C | $25.7M | 2025-05-30 |
| Aravax | Melbourne | Series B | $22.2M | 2024-01-23 |
| MISTI | Melbourne | Pre-seed | $120K | 2023-09-15 |
| Resseptor Therapeutics | Melbourne | Seed | $1.5M | 2023-05-24 |
4 rows of the CSV in 5 of its 18 columns.
- The 32 biotech startups in Melbourne, Australia have raised $107.8M in total.
- 2 of them closed their most recent round in the last 12 months, $10.3M combined.
- The largest of those rounds is Skopos Bio's $8.3M seed round, dated September 2026.
- Brandon Capital is an investor in 2 of them, more than any other fund.
- Health care is the most common other sector, with 28 companies (88%).
- 38% were founded in 2020 or later; the median founding year is 2017.
- The most common team size is 1 to 10 employees (72% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
3 of 32| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| PolyActiva | PolyActiva develops products that enable drug release from medical devices. | Biotech | Series C | $25.7M | 2025-05-30 | $38.2M | Brandon Capital, Yuuwa Capital, Medical Research Commercialisation Fund (MRCF) +1 | 11 to 50 | 2009 |
| Aravax | Aravax is an early stage biotechnology company developing a treatment for peanut allergy. | Biotech | Series B | $22.2M | 2024-01-23 | Novartis Venture Fund, Breakthrough Victoria, Uniseed +2 | 11 to 50 | 2015 | |
| MISTI | MISTI develops low-cost, validated, rapid lung delivery systems. | Biotech | Pre-seed | $120K | 2023-09-15 | Startmate | 1 to 10 | 2022 |
Table 1. Biotech startups in Melbourne, Australia: the 3 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 32.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Brandon Capital | Private equity firm | Melbourne, Australia | 2 | 6% | ||
| 2 | Uniseed | Venture capital firm | Brisbane, Australia | 2 | 6% | ||
| 3 | Yuuwa Capital | Micro VC fund | Perth, Australia | 1 | 3% | ||
| 4 | Medical Research Commercialisation Fund (MRCF) | Venture capital firm | Melbourne, Australia | 1 | 3% | ||
| 5 | State Government of Victoria | Government investment office | Melbourne, Australia | 1 | 3% | ||
| 6 | Breakthrough Victoria | Venture capital firm | Melbourne, Australia | 1 | 3% | ||
| 7 | Novartis Venture Fund | Corporate venture arm | Basel, Switzerland | 1 | 3% | ||
| 8 | Tenmile | Private equity firm | Perth, Australia | 1 | 3% | ||
| 9 | Startmate | Startup accelerator | Melbourne, Australia | 1 | 3% | ||
| 10 | IP Group Australia | Venture capital firm | Melbourne, Australia | 1 | 3% | ||
| 11 | Accelerating Commercialisation - AusIndustry | Government investment office | Canberra, Australia | 1 | 3% | ||
| 12 | Tin Alley Ventures | Venture capital firm | Carlton, Australia | 1 | 3% | ||
| 13 | Rampersand | Venture capital firm | Melbourne, Australia | 1 | 3% | ||
| 14 | Possible Ventures | Venture capital firm | Munich, Germany | 1 | 3% | ||
| 15 | Brisbane Angels | Angel group | Brisbane, Australia | 1 | 3% |
Table 2. Biotech startups in Melbourne, Australia: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 28 | 88% | $83.0M |
| Software | 5 | 16% | $171K |
| Hardware | 2 | 6% | |
| Artificial intelligence | 1 | 3% |
Table 3. Biotech startups in Melbourne, Australia by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Pre-seed | 6 | 19% | $171K |
| Seed | 18 | 56% | $1.5M |
| Series A | 4 | 12% | $16.0M |
| Series B | 3 | 9% | $22.2M |
| Series C | 1 | 3% | $25.7M |
Table 4. Biotech startups in Melbourne, Australia by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| September 2026 | 1 | 50% | $8.3M |
| June 2026 | 1 | 50% | $2.0M |
Table 5. Biotech startups in Melbourne, Australia: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 2 | 6% | $10.3M |
| 2025 | 5 | 16% | $47.8M |
| 2024 | 4 | 12% | $23.3M |
| 2023 | 2 | 6% | $1.6M |
| 2022 | 4 | 12% | $16.0M |
| 2021 | 1 | 3% |
Table 6. Biotech startups in Melbourne, Australia by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 5 | 16% |
| 2020 to 2022 | 7 | 22% |
| 2015 to 2019 | 11 | 34% |
| 2010 to 2014 | 8 | 25% |
| Before 2010 | 1 | 3% |
Table 7. Biotech startups in Melbourne, Australia by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 23 | 72% |
| 11 to 50 | 8 | 25% |
| 51 to 100 | 1 | 3% |
Table 8. Biotech startups in Melbourne, Australia by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its headquarters is in Melbourne, Australia. On 16 November 2026 that is 32 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 3 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 32 rows: 10 have no round amount, 0 no city and 13 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Melbourne, Australia are on the list?
- 32, in the file dated 16 November 2026. 2 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 32 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.